← Back to Search

Heat Therapy for Type 2 Diabetes

N/A
Recruiting
Research Sponsored by Montreal Heart Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 45-75 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 12 weeks
Awards & highlights

Study Summary

This trial will investigate if heat exposure improves metabolic functions in people with type 2 diabetes mellitus, which could help reduce their risk of cardiovascular diseases.

Who is the study for?
This trial is for men and women aged 45-75 with type 2 diabetes diagnosed at least a year ago, who have been on stable medication for the past 12 weeks. It's not suitable for those with severe heart, kidney or lung diseases, very high obesity (Class 3), uncontrolled hypertension, serious nerve or eye damage from diabetes, those using insulin therapy, or with very high blood fat or cholesterol levels.Check my eligibility
What is being tested?
The study is exploring whether sitting in hot water can improve heart health and sugar metabolism in people with type 2 diabetes. Participants will undergo heat therapy sessions over a period of 12 weeks to see if it helps manage fatty acids after eating, improves insulin sensitivity and benefits the lining of their blood vessels.See study design
What are the potential side effects?
Potential side effects may include discomfort due to heat exposure such as sweating or dizziness. Long-term effects are unknown but could involve changes in skin condition due to frequent hot water immersion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 45 and 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1C (HbA1C)
Secondary outcome measures
Arterial stiffness
Blood pressure
Insulin
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: HeatExperimental Treatment1 Intervention
Participants will immerse their feet in a foot bath with water maintained at 42°C
Group II: ThermoneutralPlacebo Group1 Intervention
Participants will immerse their feet in a foot bath with water maintained at 36°C

Find a Location

Who is running the clinical trial?

Montreal Heart InstituteLead Sponsor
120 Previous Clinical Trials
68,775 Total Patients Enrolled

Media Library

Home-based Heat Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05269589 — N/A
Type 2 Diabetes Research Study Groups: Thermoneutral, Heat
Type 2 Diabetes Clinical Trial 2023: Home-based Heat Therapy Highlights & Side Effects. Trial Name: NCT05269589 — N/A
Home-based Heat Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05269589 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this research still available?

"Data from clinicaltrials.gov illustrates that this medical experiment is currently searching for participants - first posted on February 18th, 2022 and recently modified on March 21st of the same year."

Answered by AI

Can I partake in the current clinical experiment?

"This trial is recruiting 44 individuals aged between 45 and 75 who are diagnosed with Type 2 diabetes mellitus. In addition to these criteria, participants must have been taking the same medication for at least 3 months prior to enrollment."

Answered by AI

Are elderly individuals welcome to participate in the experiment?

"This trial is exclusively open to patients between 45 and 75 years of age."

Answered by AI

What is the current participant count in this trial?

"Affirmative. Clinical trials website records indicate that this medical study is presently searching for participants, having been first published on February 18th 2022 and last edited on March 21st 2022. The trial requires 44 individuals to be recruited from one site."

Answered by AI
~9 spots leftby Dec 2024